INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 277 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $1,115,016 | +39.6% | 15,569 | +1.5% | 0.01% | +40.0% |
Q3 2023 | $798,729 | +24.9% | 15,334 | +51.9% | 0.01% | +25.0% |
Q2 2023 | $639,341 | +18.2% | 10,097 | +1.1% | 0.01% | +14.3% |
Q1 2023 | $541,012 | +15.3% | 9,991 | +12.7% | 0.01% | 0.0% |
Q4 2022 | $469,040 | +18.7% | 8,863 | +4.4% | 0.01% | +16.7% |
Q3 2022 | $395,000 | -3.7% | 8,486 | +18.1% | 0.01% | 0.0% |
Q2 2022 | $410,000 | – | 7,184 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 360,000 | $11,502,000 | 2.65% |
Redmile Group, LLC | 610,171 | $19,495,000 | 1.60% |
Pier Capital, LLC | 257,256 | $8,219,000 | 1.18% |
WALL STREET ASSOCIATES | 358,857 | $11,465,000 | 1.08% |
SENZAR ASSET MANAGEMENT, LLC | 161,300 | $5,154,000 | 0.88% |
Rhenman & Partners Asset Management AB | 206,000 | $6,582,000 | 0.79% |
EAM Investors, LLC | 152,389 | $4,869,000 | 0.57% |
EDMOND DE ROTHSCHILD (SUISSE) S.A. | 50,000 | $1,598,000 | 0.51% |
Visium Asset Management, LP | 1,051,479 | $33,595,000 | 0.48% |
SPHERA FUNDS MANAGEMENT LTD. | 128,000 | $4,090,000 | 0.40% |